Novo Nordisk has secured a significant regulatory victory, following the United States Food and Drug Administration’s approval of its new weight loss pill containing semaglutide. The decision delivers the Danish
All posts tagged in obesity
10Articles
Scotland’s National Health Service saw a dramatic increase in the prescription of semaglutide, known commercially as Ozempic and Wegovy, as the annual number of prescriptions rose to 168,486 in 2024
Weight loss injections have rapidly transformed the British approach to tackling obesity, with an extraordinary surge in private usage. Latest data suggests that 2.5 million adults in the UK—one in
Novo Nordisk, headquartered in Copenhagen, has seen its shares surge by more than 6 per cent after unveiling promising results from a late-stage clinical trial of its new anti-obesity tablet.
Eli Lilly, one of the world’s largest pharmaceutical companies, has temporarily halted orders of its highly sought-after weight-loss injection, Mounjaro, to the UK. This move comes as the market braces
Weight loss medications, specifically GLP1 agonists like Ozempic Wegovy and Mounjaro, are redefining the landscape of healthcare in Britain, with new research signposting not only longer lives for millions but
The UK market for private weight loss drugs is bracing itself for seismic change as Eli Lilly announces dramatic price increases for its popular Mounjaro injections. Over 1.5 million Britons
In today’s world, ultra-processed and fast food have become pervasive, infiltrating every aspect of our lives. These products, often masked by clever branding and marketing strategies, pose significant risks to
A recent poll conducted by Ipsos for the Health Foundation thinktank has revealed that a majority of people in Britain are in favor of introducing new taxes on companies that
Arecor Therapeutics PLC, listed on AIM as AREC, has been making waves in the healthcare industry with its innovative approach to diabetes and obesity treatments. In a recent interview with
